Susceptibility to Paget's disease is associated with reduced optineurin expression
Optineurin knockdown enhances osteoclast differentiation
Loss of optineurin function increases bone turnover in vivo
Optineurin inhibits osteoclast formation by modulating NF-κB and IFN-β signaling